Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1026
H.R.1026: LABEL Opioids Act
About This Bill
- Introduced Feb. 11, 2021
- Latest Major Action April 28, 2021
Bill Sponsor
Bill Cosponsors
8 (6 Democrats, 2 Republicans)
Bill Version
- Introduced in House - Feb. 11, 2021
Bill Summary
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
April 28, 2021 |
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
|
Feb. 12, 2021 |
Referred to the Subcommittee on Health.
|
Feb. 11, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Feb. 11, 2021 |
Introduced in the House by Greg Stanton (D-Ariz.) |